Cameroon vs Cyprus: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Cameroon
82.0%
in 2025
Cyprus
83.0%
in 2025
Cameroon rank
106th
Cyprus rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Cameroon
- Cyprus
How they compare
Cyprus currently reports 83.0% against 82.0% in Cameroon, a difference of 1.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Cyprus ahead.
Cameroon ranks 106th and Cyprus ranks 104th of 194 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Cyprus in 1.
Head to head by decade
| Decade | Cameroon | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.2% | 40.5% | 21.7% | Cameroon |
| 2020s | 73.7% | 80.3% | 6.7% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Cameroon or Cyprus?
- Cyprus, at 83.0% against 82.0% in Cameroon as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Cameroon and Cyprus?
- 1.0%, with Cyprus ahead.
- How many years of comparable data are there for Cameroon and Cyprus?
- 18 years are reported by both, from 2008 to 2025.
- How do Cameroon and Cyprus rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Cameroon ranks 106th and Cyprus ranks 104th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.